A Comparative study of Shwasahara Dashemani in the Management of Tamaka Shwasa(Bronchial Asthma)in Children-A randomized open label clinical Trail - EOSDOTS

Director IPGT and RA GAU JAMNAGAR0 个研究点目标入组 52 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients of 2 â?? 12 years of age of either sex.
•Diagnosed cases of Tamaka Shwasa with at least 2 episodes of asthma symptoms during the previous year.
•Mild persistent asthmatic patients.
•Patients on other drug therapy will be included only after completion of wash out period of three weeks.

•Children of age below 2 years and above 12 years.
•Patients with status asthmatics.
•Evidence of active Concomitant Pulmonary Diseases other than asthma.
•Evidence of requirement of intubations for asthma, or had been hospitalized for asthma within one month before, Unresolved Sinus Disease or an unresolved upper or lower respiratory tract infection within 2 weeks.
•Concomitant severe systemic disease (cardiovascular, renal, hepatic, endocrine, haematological, neurologicaletc.)

发起方

Director IPGT and RA GAU JAMNAGAR